JPRN-UMIN000005465已完成未知
Effects of tolvaptan in congestive heart failure patients with renal dysfunction - Effects of tolvaptan in congestive heart failure patients with renal dysfunction
Department of cardiology Osaka city university graduate school of medicine0 个研究点目标入组 200 人开始时间: 2011年4月25日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients who a history of hypersensitivity to tolvaptan 2) Patients with severe hypotention or cardioganic shock 3) Patients with cardiac assist device 4) Patients with dehydration 5) Patients with systolic blood pressure < 90mmHg 6) Patients with serum Na > 147 mEq/L or serum K > 5.5 mEq/L or T- bilirubin > 3.0 mg/dL 7)Patients considered not eligible for the study by the attending doctor due to other reasons
研究者
相似试验
已完成
不适用
The effect of tolvaptan in heart failure patients with loop diuretic resistance.heart failureJPRN-UMIN000016655Tokyo Women's Medical University, Department of Cardiology50
已完成
不适用
Efficacy of Tolvaptan in heart failure patients with preserved Ejection fraction: multicenter, RaNdomized, open-label triAL (ETERNAL)Heart Failure with Preserved Ejection Fraction (HFPEF)JPRN-UMIN000011012agoya University Graduate School of Medicine, Department of Cardiology100
Enrolling By Invitation
不适用
Efficacy of Tolvaptan in acute heart failure patients with preserved left ventricular ejection fractioacute decompensated heart failureJPRN-UMIN000013727Osaka General Medical Center120
招募中
不适用
Efficacy and Safety Evaluation of Tolvaptan in the Treatment of Patients With RHF Caused by PAHRandomized Controlled TrialPulmonary Arterial HypertensionNCT05569655Chinese Pulmonary Vascular Disease Research Group100
已完成
不适用
Efficacy and Safety of Tolvaptan in Heart Failure Patients with Renal Impairment and Volume Overload Despite the Standard Treatment with Conventional DiureticsHeart FailureJPRN-UMIN000009201Kanagawa Aquaresis Investigators100